XON
XON Real Time Price USDRecent trades of XON by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by XON's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Oct 20, 2020 Issue: None
-
$20,000 Apr 20, 2020 Issue: None
-
$20,000 Apr 22, 2019 Issue: Trade (domestic/foreign) Agriculture
-
$180,000 Apr 17, 2019 Issue: Budget/Appropriations Energy/Nuclear Food Industry (safety, labeling, etc.) Science/Technology Agriculture
-
$20,000 Apr 15, 2019 Issue: Agriculture
-
$20,000 Jan 22, 2019 Issue: Trade (domestic/foreign) Agriculture
-
$20,000 Jan 22, 2019 Issue: Food Industry (safety, labeling, etc.) Energy/Nuclear Budget/Appropriations Science/Technology Agriculture
-
$30,000 Jul 20, 2018 Issue: Budget/Appropriations Agriculture
-
$20,000 Jul 20, 2018 Issue: Energy/Nuclear Trade (domestic/foreign) Agriculture
-
$50,000 Jul 17, 2018 Issue: Energy/Nuclear Budget/Appropriations Agriculture Food Industry (safety, labeling, etc.) Science/Technology
-
$80,000 Apr 30, 2018 Issue: Science/Technology Food Industry (safety, labeling, etc.) Energy/Nuclear Budget/Appropriations Agriculture
-
$40,000 Apr 20, 2018 Issue: Budget/Appropriations Health Issues Agriculture
-
$20,000 Apr 20, 2018 Issue: Trade (domestic/foreign) Agriculture
-
$50,000 Apr 20, 2018 Issue: Budget/Appropriations
-
$110,000 Apr 20, 2018 Issue: Budget/Appropriations
-
$230,000 Jan 22, 2018 Issue: Budget/Appropriations Health Issues Agriculture
-
$20,000 Jan 22, 2018 Issue: Energy/Nuclear Trade (domestic/foreign) Medical/Disease Research/Clinical Labs
-
$200,000 Jan 22, 2018 Issue: Science/Technology Medical/Disease Research/Clinical Labs Food Industry (safety, labeling, etc.) Health Issues Agriculture Energy/Nuclear
-
$50,000 Jan 17, 2018 Issue: Budget/Appropriations
-
$110,000 Jan 17, 2018 Issue: Budget/Appropriations
-
$100,000 Oct 20, 2017 Issue: Health Issues
-
$230,000 Oct 20, 2017 Issue: Science/Technology Medical/Disease Research/Clinical Labs Energy/Nuclear Health Issues Agriculture Food Industry (safety, labeling, etc.)
-
$110,000 Oct 18, 2017 Issue: Budget/Appropriations
-
$50,000 Oct 18, 2017 Issue: Budget/Appropriations
-
$20,000 Aug 09, 2017 Issue: Budget/Appropriations
-
$190,000 Jul 20, 2017 Issue: Health Issues
-
$280,000 Jul 19, 2017 Issue: Science/Technology Energy/Nuclear Health Issues Agriculture Food Industry (safety, labeling, etc.) Medical/Disease Research/Clinical Labs
-
$60,000 Jul 18, 2017 Issue: Budget/Appropriations
-
$20,000 Jul 18, 2017 Issue: Budget/Appropriations
-
$230,000 Apr 20, 2017 Issue: Science/Technology Agriculture Medical/Disease Research/Clinical Labs Energy/Nuclear Health Issues
-
$280,000 Apr 20, 2017 Issue: Health Issues
-
$230,000 Mar 23, 2017 Issue: Health Issues
-
$130,000 Jan 19, 2017 Issue: Science/Technology Medical/Disease Research/Clinical Labs Health Issues Agriculture
Estimated quarterly lobbying spending
XON Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to XON
Recent picks made for XON stock on CNBC
ETFs with the largest estimated holdings in XON
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $XON stock a Buy, Sell, or Hold?
- What is the price target for $XON stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $XON stock?
- Who owns the most shares of $XON stock?
- What funds own $XON stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view XON Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
No description available